Catalent

Activities: Manufacturing Ingredients Research & Development

Trending Articles

  1. New study poised to shift how the nutraceutical industry thinks about NAD+ support Researchers have uncovered that the botanical complex BluNADBooster outperformed the category’s benchmark precursor ingredient, nicotinamide riboside — commercially sold as...
  2. Clasado to unveil new female athlete prebiotic research on Bimuno GOS at ISENC 2025 Elite athlete study shows Bimuno GOS delivers significant benefits for immunity, gut health and sleep, offering fresh insights into female sports performance
  3. Natural Remedies explores possible GLP-1 support function of its digestive health ingredient Natural Remedies' patented digestive health ingredient GutGard completed a preclinical investigation in October 2025, with a new human clinical study in January 2026 examining...
  4. 2025 has been a landmark year for prebiotics according to Clasado The company reflects on a successful 2025, during which prebiotic science began to gain momentum in health and nutrition product innovation
  5. Lupin, TPG Capital & EQT in talks to acquire Vitabiotics in £1bn takeover Indian pharmaceutical giant Lupin Pharma is reportedly in early-stage negotiations to acquire UK supplement leader Vitabiotics for around £1 billion to capitalise on booming...

Upcoming event

Vitafoods India

11–13 February 2026 | Exhibition | Mumbai See all

Related Content

Ingredients

Chewable Supplements at SupplySide West, Booth 3171

At this year’s SupplySide West show in Las Vegas Oct 31-Nov 4, visit Catalent’s Consumer Health business in Booth 3171 to experience what’s next in chewable supplements
Ingredients

Catalent announces major segment restructure

The global leader in biopharma, cell, gene, and consumer health partnerships has consolidated from four reporting segments to two
Ingredients

Nutraceutical Business Review in conversation with Catalent

In this exclusive video interview, NBR talks to Catalent's VP of Global Marketing & Strategy for Consumer Health, Dan Peizer, about gummies, the millennial attitude, and the 'perfect storm' for a nutraceutical growth period
Dietary supplements

Consumers are choosing ‘experiential’ in supplements

A major trend that was emerging before the pandemic, but has accelerated during the pandemic, is consumers looking to categories and delivery formats that offer a distinct experience in the categories and delivery forms they choose
Dietary supplements

WEBINAR: The Growth of Premium in Nutritional Supplements

The webinar, which took place 27 September 2021, is now available to watch on demand
Ingredients

Catalent to acquire gummy and soft chew manufacturer

Bettera has four production facilities in the US where it develops and produces products for nutraceutical ingredients
Manufacturing

HBC and Catalent partner on delayed-release fish oil capsules

Catalent’s technology reportedly enables an enteric release profile for softgel capsules without the need for an additional external coating
Subscribe now